meta
|
Preg
- medecines during pregnancy KB
Search
Metronidazole (all routes except local only)
Overall results
Study description
Excluded studies
Table
Graphic
auto
during pregnancy (anytime or not specified)
1st trimester
2nd trimester
3rd trimester
2nd and/or 3rd trimester
throughout pregnancy
early pregnancy
days before delivery
late pregnancy
preconception-only
periconceptional
preconceptional for kinetic reason
at least 1st trimester
3 months (or more) before pregnancy or during pregnancy
1st and 2nd trimester
3 months or more before pregnancy or1st trimester
Whatever the period exposition
individual studies
Outcome
TE
95% CI
n cases
n exposed
k
Pub. bias
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)
Heinonen (Controls unexposed, NOS), 1977 Rosa, 1987 Piper, 1993 Caro-Paton, 1997 Czeizel, 1998 Sorensen, 1999 Diav-Citrin, 2001 Koss, 2012 Muanda a (Controls unexposed, NOS), 2017
9
1.10
[
0.97
; 1.26]
61,391
3,716
not evaluable
Major congenital malformations
Heinonen (Controls unexposed, NOS), 1977 Piper, 1993 Czeizel, 1998 Diav-Citrin, 2001 Koss, 2012 Muanda a (Controls unexposed, NOS), 2017
6
1.15
[
0.98
; 1.34]
32,083
2,509
not evaluable
Congenital heart defects
Piper, 1993 Czeizel, 1998 Muanda a (Controls unexposed, NOS), 2017
3
0.92
[
0.63
; 1.34]
5,653
1,907
not evaluable
Cleft palate
Czeizel, 1998 Muanda a (Controls unexposed, NOS), 2017
2
0.49
[
0.10
; 2.52]
672
575
not evaluable
Limb defects
Piper, 1993 Muanda a (Controls unexposed, NOS), 2017
2
0.98
[
0.68
; 1.40]
4,935
1,730
not evaluable
Nervous system anomalies
Piper, 1993 Muanda a (Controls unexposed, NOS), 2017
2
0.66
[
0.34
; 1.25]
760
1,730
not evaluable
Respiratory system anomalies
Piper, 1993 Muanda a (Controls unexposed, NOS), 2017
2
1.07
[
0.32
; 3.64]
571
1,730
not evaluable
Cardiac septal defects
Muanda a (Controls unexposed, NOS), 2017
1
1.18
[
0.58
; 2.40]
1,876
412
not evaluable
Club foot / Talipes equinovarus
Czeizel, 1998 Werler, 2014
2
1.26
[
0.68
; 2.30]
2,459
184
not evaluable
Craniosynostosis
Muanda a (Controls unexposed, NOS), 2017
1
1.37
[
0.43
; 4.37]
636
412
not evaluable
Digestive system anomalies
Muanda a (Controls unexposed, NOS), 2017
1
1.13
[
0.46
; 2.76]
1,104
412
not evaluable
Eye, ear, face and neck malformations
Muanda a (Controls unexposed, NOS), 2017
1
0.88
[
0.22
; 3.49]
737
412
not evaluable
Genital anomalies
Muanda a (Controls unexposed, NOS), 2017
1
0.54
[
0.13
; 2.21]
1,152
412
not evaluable
Urinary malformations
Muanda a (Controls unexposed, NOS), 2017
1
1.53
[
0.63
; 3.71]
942
412
not evaluable
Ano-rectal atresia and stenosis
Czeizel, 1998
1
3.35
[
1.05
; 10.66]
160
165
not evaluable
Chromosomal abnormalities
Piper, 1993
1
0.20
[
0.01
; 4.17]
2
1,318
not evaluable
Cleft lip with or without cleft palate
Czeizel, 1998
1
1.67
[
0.85
; 3.29]
1,007
171
not evaluable
Diaphragmatic hernia
Czeizel, 1998
1
1.77
[
0.44
; 7.16]
211
164
not evaluable
Ear malformations
Czeizel, 1998
1
0.35
[
0.02
; 5.68]
267
162
not evaluable
Gastroschisis
Czeizel, 1998
1
1.02
[
0.14
; 7.40]
193
163
not evaluable
Hydrocephaly
Czeizel, 1998
1
3.48
[
1.41
; 8.57]
278
167
not evaluable
Hypospadias
Czeizel, 1998
1
1.04
[
0.58
; 1.87]
2,217
174
not evaluable
Limb reduction defects (LRD)
Czeizel, 1998
1
0.85
[
0.21
; 3.45]
424
164
not evaluable
Microcephaly / Small head circumference for gestational age
Abdel-Salam (All routes), 2000
1
0.40
[
0.10
; 1.55]
109
16
not evaluable
Minor congenital malformations
0
-
-
-
-
-
Neural Tube Defects
Medveczky, 2004
1
1.60
[
0.67
; 3.82]
1,202
90
not evaluable
Polydactyly
Czeizel, 1998
1
1.86
[
1.03
; 3.36]
1,266
174
not evaluable
Growth parameters and prematurity
Preterm (< 37 weeks)
Sorensen, 1999 Diav-Citrin, 2001 Jeffcoat, 2003 Santos, 2012 Koss, 2012
5
1.32
[
0.86
; 2.03]
1,195
1,398
not evaluable
Low birth weight (< 2500g)
Koss, 2012
1
0.96
[
0.69
; 1.34]
262
921
not evaluable
Small for gestational age (weight)
Santos, 2011
1
0.98
[
0.72
; 1.34]
8,192
323
not evaluable
Very low birth weight (< 1500g)
Piper, 1993
1
1.15
[
0.69
; 1.92]
60
1,318
not evaluable
Neonatal disorders
Neonatal antibiotic resistance
Wright, 2012
1
2.90
[
0.11
; 74.14]
32
2
not evaluable
Long term consequences
Leukemia
Ross, 2003 Pombo-de-Oliveira, 2006
2
1.39
[
0.85
; 2.27]
445
90
not evaluable
Cancer (all kind) in children or adults
Thapa, 1998
1
0.81
[
0.41
; 1.60]
175
-
not evaluable
Central Nervous System (CNS) tumors
Thapa, 1998
1
1.23
[
0.29
; 5.21]
30
-
not evaluable
Neuroblastoma
Thapa, 1998
1
2.60
[
0.89
; 7.59]
28
-
not evaluable
Intrauterine deaths
Early intrauterine death (< 22 weeks)
Diav-Citrin, 2001 Muanda b (Controls unexposed, NOS), 2017
2
1.47
[
0.98
; 2.21]
8,762
248
not evaluable
Late intrauterine deaths (> 22 weeks)
Piper, 1993 Diav-Citrin, 2001
2
0.54
[
0.18
; 1.68]
13
1,526
not evaluable
Ectopic pregnancy
0
-
-
-
-
-
Elective/induced termination of pregnancy
Diav-Citrin, 2001
1
3.41
[
1.86
; 6.25]
45
228
not evaluable
Neuro-developmental disorders
Cognitive developmental disorders/delay (> 6 years old)
Mann, 2009
1
1.07
[
0.79
; 1.44]
-
-
not evaluable
Severe cognitive developmental delay (Mental retardation) (> 6 years old)
Mann, 2009
1
0.72
[
0.35
; 1.47]
-
-
not evaluable
0.0
100.0
1.0